基于真实世界美国联邦医疗保险按服务付费索赔数据评估一线心脏正电子发射断层成像(PET)成像的下游价值
该回顾性观察研究利用美国联邦医疗保险按服务付费数据集,纳入初始成像前1年内无冠状动脉疾病(CAD)诊断的受试者,比较一线心脏PET与倾向评分匹配的常规成像(单光子发射计算机断层成像或负荷超声心动图)的下游价值。匹配后每组4619例,PET组辐射暴露更低、不稳定冠状动脉综合征发生率更低,但住院更多、经皮冠状动脉介入治疗更多,死亡率相似,医疗支出更高。结论认为一线PET成像未与利用率和支出降低相关,临床结局大多相似。
要点
- 匹配后每组4619例,PET组年辐射暴露较常规成像组少3.8毫希沃特(95%CI -3.96至-3.64,P<.0001)。
- PET组不稳定冠状动脉综合征发生率低于常规成像组(IRR 0.77,95%CI 0.64-0.94,P=.008)。
- PET组住院更多(IRR 1.10,95%CI 1.06-1.15,P<.0001),经皮冠状动脉介入治疗更多(IRR 1.24,95%CI 1.02-1.50,P=0.03)。
核心结论
- 一线PET成像未与利用率和支出水平降低相关,临床结局大多相似。
研究设计与样本
- 该研究为回顾性观察研究,使用美国联邦医疗保险按服务付费数据集。
- 受试者在初始成像前1年内无CAD诊断,PET组接受PET成像,倾向评分匹配对照组接受单光子发射计算机断层成像或负荷超声心动图,索引成像时间在2014年1月至2016年12月之间。
- 共纳入144503例受试者,其中4619例(3.2%)接受PET,139884例(96.8%)接受常规成像。
- 匹配后每组各4619例,平均年龄74岁,女性占59%。
- 结局使用广义线性模型分析。
主要发现
- PET组年辐射暴露较常规成像组少3.8毫希沃特(95%CI -3.96至-3.64,P<.0001)。
- PET组不稳定冠状动脉综合征发生率低于常规成像组(IRR 0.77,95%CI 0.64-0.94,P=.008)。
- PET组住院风险高于常规成像组(IRR 1.10,95%CI 1.06-1.15,P<.0001)。
- PET组经皮冠状动脉介入治疗使用多于常规成像组(IRR 1.24,95%CI 1.02-1.50,P=0.03)。
- PET组与常规成像组死亡率相似(风险比0.95,95%CI 0.78-1.14,P=0.55)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Higher imaging quality makes cardiac positron emission tomography (PET) desirable for evaluation of suspected coronary artery disease (CAD). High cost of PET imaging may be offset by reduced utilization and/or improved outcomes. METHODS: This retrospective observational study utilized Medicare fee-for-service dataset. Study participants had no CAD diagnosis within 1 year prior to initial imaging. The PET group (PET imaging) and propensity score matched comparison group (single photon emission computed tomography or stress echocardiography) underwent index imaging between January 2014 and December 2016. Outcomes were analyzed using generalized linear models. RESULTS: Among 144,503 study subjects, 4619 (3.2%) had PET and 139,884 (96.8%) had conventional imaging. After matching, each group had 4619 patients (mean age 74 years, 59% female). The PET group had lower radiation exposure (3.8 milliSievert less per year, 95% CI - 3.96 to - 3.64, P < .0001) and unstable coronary syndrome (incidence rate ratio (IRR) 0.77, 95% CI 0.64-0.94, P = .008). The PET group experienced more hospital admissions (IRR 1.10, 95% CI 1.06-1.15, P < .0001), more use of percutaneous coronary intervention (IRR 1.24, 95% CI 1.02-1.50, P = 0.03), while similar mortality rate (hazard ratio 0.95, 95% CI 0.78-1.14, P = 0.55). The PET group had higher medical spending ($2358.2 vs $1774.3, difference = $583.9 per patient per month, P < .0001). CONCLUSIONS: First-line PET imaging was not associated with reduced levels of utilization and spending. Clinical outcomes were mostly similar.
引用
- Ma Q, Sridhar G, Power T, et al. Assessing the downstream value of first-line cardiac positron emission tomography (PET) imaging using real world Medicare fee-for-service claims data. J Nucl Cardiol. 2019. PMID: 31820411. doi:10.1007/s12350-019-01974-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。